Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes (Q44655656)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 1, 2003

Language	Label	Description	Also known as
English	Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes	scientific article published on November 1, 2003

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes (English)

1 reference

Europe PubMed Central

5 December 2017

1 reference

based on heuristic

inferred from title

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

internal medicine

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

author name string

J. S. Christiansen

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14617231

1 April 2024

J. A. Vaz

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14617231

1 April 2024

Z. Metelko

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14617231

1 April 2024

M. Bogoev

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14617231

1 April 2024

I. Dedov

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14617231

1 April 2024

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14617231

1 April 2024

publication date

1 November 2003

1 reference

Europe PubMed Central

5 December 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1463-1326.2003.00300.x

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1463-1326.2003.00300.x/fullpdf

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

5 December 2017

5

1 reference

Europe PubMed Central

5 December 2017

6

1 reference

Europe PubMed Central

5 December 2017

446-454

1 reference

Europe PubMed Central

5 December 2017

The effects of improved glycemic control on complications in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Postprandial glycemic control with biphasic insulin aspart in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Injection-meal interval: recommendations of diabetologists and how patients handle it.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Aspartame metabolism in normal adults, phenylketonuric heterozygotes, and diabetic subjects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Relationship of glycosylated hemoglobin to oral glucose tolerance. Implications for diabetes screening

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.2337/DIAB.37.1.60

Glycosylated hemoglobins and glycosylated plasma proteins in the diagnosis of diabetes mellitus and impaired glucose tolerance.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.2337/DIACARE.7.2.147

Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes

6

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes

12

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspart

14

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Insulin aspart in a 30/70 premixed formulation. Pharmacodynamic properties of a rapid-acting insulin analog in stable mixture

15

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

The utility of glycated hemoglobin in identification of impaired glucose tolerance

18

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

The relative value of glycated albumin, hemoglobin A1c and fructosamine when screening for diabetes mellitus

19

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Postprandial hyperglycaemic state: importance and consequences

20

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Hyperglycemia and microvascular and macrovascular disease in diabetes

21

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

24

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

27

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

28

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

29

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Identifiers

10.1046/J.1463-1326.2003.00300.X

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44655656&oldid=2118757341"